Organization
MedImmune LLC
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
MedImmune LLC
... AstraZeneca Plc (LSE:AZ), a global, science-led biopharmaceutical company, and MedImmune=1% of tumour cells and whose disease has not progressed following platinum-based chemotherapy ...
... AstraZeneca and MedImmune, its global biologics research and development arm, have presented data on overall ...
... adolescents, and adults ages 2 through 49. FLUMIST QUADRIVALENT is similar to MedImmune's trivalent influenza vaccine, except FLUMIST QUADRIVALENT provides protection against an additional influenza ...
... AstraZeneca and MedImmune, its global biologics research and development arm, announced today that the US ...
... with a high unmet medical need. In January 2018, Innate Pharma and MedImmune, the global biologics research and development arm of AstraZeneca, entered into a ...
... AstraZeneca and MedImmune, its global biologics research and development arm, announced today that the US ...
... trials next year. The new VC funding follows recent agreements with AstraZeneca's MedImmune unit and Roche to develop multiple AAV-based gene therapy products. In July, ...
... now in a phase 2 clinical trial. The antibody was licensed to MedImmune, a wholly owned subsidiary of the pharmaceutical giant AstraZeneca that entered into ...
... AstraZeneca and MedImmune, its global biologics research and development arm, today announced top-line results from ...
... Dr Vaughan is Vice President R&D Antibody Discovery and Protein Engineering for MedImmune, the global biologics research and development arm of AstraZeneca. He has held ...
Subscribe now for full coverage on MedImmune LLC
Start My Free Trial